Plasma amyloid-β biomarkers are associated with Alzheimer′s disease comorbidity in Lewy body disease

被引:1
作者
Noguchi-Shinohara, Moeko [1 ]
Murakami, Hidetomo [2 ]
Sakashita, Yasuhiro [1 ]
Mori, Yukiko [2 ]
Komatsu, Junji [1 ,3 ]
Muramatsu, Daiki [1 ]
Hikishima, Sadao [1 ]
Ono, Kenjiro [1 ]
机构
[1] Kanazawa Univ, Dept Neurol, Grad Sch Med Sci, 13-1 Takara Machi, Kanazawa 9208640, Japan
[2] Showa Univ, Sch Med, Dept Neurol, Tokyo, Japan
[3] Kanazawa Univ, Dept Preempt Med Dementia, Grad Sch Med Sci, Kanazawa, Japan
关键词
Lewy body disease; Plasma amyloid-ss; Alzheimer pathology;
D O I
10.1016/j.parkreldis.2023.105445
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
No blood biomarkers which can identify Alzheimer's disease pathology in Lewy body disease (LBD) have ever been established. We showed that the plasma amyloid-ss (A ss) (1-42)/A ss(1- 40) ratio was significantly decreased in patients with A ss+ LBD compared with those with A ss- LBD and it might be a useful biomarker.
引用
收藏
页数:3
相关论文
共 5 条
[1]  
Chouliaras L., J NEUROL NEUROSUR PS, V0
[2]  
Morinaga A., DEMENT GERIATR COGN, V30
[3]   Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration [J].
Murakami, Kazuma ;
Ono, Kenjiro .
FASEB JOURNAL, 2022, 36 (09)
[4]   High performance plasma amyloid-β biomarkers for Alzheimer's disease [J].
Nakamura, Akinori ;
Kaneko, Naoki ;
Villemagne, Victor L. ;
Kato, Takashi ;
Doecke, James ;
Dore, Vincent ;
Fowler, Chris ;
Li, Qiao-Xin ;
Martins, Ralph ;
Rowe, Christopher ;
Tomita, Taisuke ;
Matsuzaki, Katsumi ;
Ishii, Kenji ;
Ishii, Kazunari ;
Arahata, Yutaka ;
Iwamoto, Shinichi ;
Ito, Kengo ;
Tanaka, Koichi ;
Masters, Colin L. ;
Yanagisawa, Katsuhiko .
NATURE, 2018, 554 (7691) :249-+
[5]   Cross-seeding effects of amyloid β-protein and α-synuclein [J].
Ono, Kenjiro ;
Takahashi, Ryoichi ;
Ikeda, Tokuhei ;
Yamada, Masahito .
JOURNAL OF NEUROCHEMISTRY, 2012, 122 (05) :883-890